Renibus Buys Tricida's Kidney Drug Veverimer In Ch. 11 Sale
Texas clinical-stage biotechnology company Renibus Therapeutics Inc. will take over the development of Tricida Inc.'s drug candidate for chronic kidney disease and could eventually pay the bankrupt San Francisco-based company up...To view the full article, register now.
Already a subscriber? Click here to view full article